Jungang Chen
Researcher
Also affiliated: Winthrop Rockefeller Foundation (2020)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jungang Chen's research focuses on understanding the mechanisms of viral infections, particularly those involving Kaposi's sarcoma-associated herpesvirus (KSHV). Chen has investigated how targeting specific proteins, such as BRD2 and BRD4, can inhibit the growth of KSHV-infected endothelial cells by suppressing LANA translation. Additionally, Chen has explored the broader implications of the oral microbiota, examining its classification, clinical significance, and potential therapeutic interventions for systemic human diseases.
Chen's scholarly work includes two publications and has garnered 20 citations, with an h-index of 2. Collaborations within the University of Arkansas for Medical Sciences include joint publications with Lu Dai and Zhiqiang Qin.
Metrics
- h-index: 2
- Publications: 2
- Citations: 20
Selected Publications
-
Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation (2026)
-
Targeting Hyaluronan Signaling Overcomes Primary Effusion Lymphoma Cells Resistance to Rapamycin (2026)
-
Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases (2026)
-
Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis (2020)
-
Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG) (2020)
Collaboration Network
Top Collaborators
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Oral Microbiota: Findings, Classification, Clinical Significance, and Therapeutic Interventions for Human Systemic Diseases
- Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation
- Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation
- Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation
Similar Researchers
Based on overlapping research topics